Vericel (VCEL) Asset Utilization Ratio (2012 - 2026)
Vericel's (VCEL) quarterly Asset Utilization Ratio came in at 0.6 in Q1 2026, up 7.82% year-on-year from 0.56 in Q1 2025, and up 2.22% quarter-over-quarter from 0.59 in Q4 2025.
Vericel (VCEL) Asset Utilization Ratio (2012 - 2026) Analysis & Trends
Vericel has disclosed Asset Utilization Ratio across 15 years of filings, most recently posting 0.6 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.6, up 7.82% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.6 (up 7.82% YoY), and the FY2025 annual result was 0.6, down 0.53% from the prior year.
- Asset Utilization Ratio came in at 0.6 for Q1 2026 at Vericel, up from 0.59 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.65 in Q1 2022 to a low of 0.56 in Q1 2025.
- The 5-year median for Asset Utilization Ratio is 0.59 (2023), against an average of 0.6.
- Across the five-year window, Asset Utilization Ratio dropped 8.73% in 2023 and grew 7.82% in 2026, its largest moves.
- Vericel's Asset Utilization Ratio stood at 0.63 in 2022, then fell by 6.67% to 0.59 in 2023, then declined by 1.98% to 0.58 in 2024, then rose by 1.84% to 0.59 in 2025, then increased by 2.22% to 0.6 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.6 (Q1 2026), 0.59 (Q4 2025), and 0.58 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Vericel | 2.04 Bn | 1.90 Bn | 49.27 Mn | 0.60 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.60 |
| Dec 31, 2025 | 0.59 |
| Sep 30, 2025 | 0.58 |
| Jun 30, 2025 | 0.58 |
| Mar 31, 2025 | 0.56 |
| Dec 31, 2024 | 0.58 |
| Sep 30, 2024 | 0.59 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | 0.59 |
| Dec 31, 2023 | 0.59 |
| Sep 30, 2023 | 0.59 |
| Jun 30, 2023 | 0.62 |
| Mar 31, 2023 | 0.63 |
| Dec 31, 2022 | 0.63 |
| Sep 30, 2022 | 0.65 |
| Jun 30, 2022 | 0.64 |
| Mar 31, 2022 | 0.65 |
| Dec 31, 2021 | 0.66 |
| Sep 30, 2021 | 0.69 |
| Jun 30, 2021 | 0.70 |